Skip to main content
SpringerLink
Log in

Endo voluntarily withdraws Opana ER from US market

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see Reactions 1657 p7; 803252542

Reference

  • Endo Pharmaceuticals. Endo Provides Update On OPANA(Rm) ER. Media Release : 6 Jul 2017. Available from: URL: http://www.endo.com

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Endo voluntarily withdraws Opana ER from US market. Reactions Weekly 1661, 3 (2017). https://doi.org/10.1007/s40278-017-33291-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-33291-3

Search

Navigation